Internal reporting often fails to reflect the true state of delivery. Our independent review provides impartial, evidence-based insight into delivery performance, risk exposure, and critical dependencies—helping you identify emerging issues early and take corrective action before timelines, budgets, and strategic outcomes are compromised.
Not sure if this is the right review? Start with a brief intake.
Know whether to continue as planned, intervene early, or reassess delivery direction before the window for recovery closes.
This diagnostic provides an independent, evidence-based view of delivery risk, enabling leadership to protect investment, make defensible decisions, and act before issues materially affect timelines, cost, or outcomes.
Expose where investment is at risk before additional funding is committed. Objective differentiation between reported progress and actual delivery reality highlights where risk is accumulating.
Replace uncertain or overly optimistic reporting with a clear, independent validation of the next move—providing the evidence required to continue, intervene, or reset with confidence.
Surface the highest-impact actions required to regain delivery control quickly, focusing on the constraints and dependencies that directly affect execution.
Commission this review when the official project narrative no longer matches delivery reality. It shows where reporting and execution have drifted apart, giving leadership the independent validation needed to correct course before outcomes are compromised.
Impartial, evidence-based validation of the true state of delivery.
Determine whether to continue as planned, intervene early, or reassess.
Prioritized actions with clear ownership to address risks and delivery discipline
The IT Delivery Health Check provides targeted delivery assurance on a single initiative, confirming or challenging the current health view without expanding into a full project audit.
| Dimension | Focus | Scope | Decision Supported | Confidence Delivered | Value at Stake | Internal Effort | Time to Insight |
|---|---|---|---|---|---|---|---|
| Focused | Rapid validation | Single project health | Continue or intervene | Directional | Protect delivery outcomes and avoid late-stage surprises | Minimal (documents + two interviews) | 5–7 days |
| Integrated | Cross-functional review | Cross-workstream interlocks | Adjust or re-baseline | High confidence | Align multi-vendor delivery and reduce cross-functional risk | Low (team-wide validation) | 7–10 days |
| Strategic | Executive assurance | Strategic viability and reset risk exposure | Proceed, pause, or reset | Board-level confidence | Protect major investment, timing, and outcome certainty | Moderate (executive input) | 10 days |
We bypass subjective status updates and assess the primary artifacts that define delivery reality, focusing only on what materially affects outcomes. This grounds the review in evidence and exposes the risks that directly impact timeline, cost, and delivery confidence.
We map the critical path and interlocks to identify where sequencing gaps, cross-team handoffs, or external dependencies create credible slippage risk.
We validate whether delivery owners—internal teams or external partners—are aligned to the current plan and accountable for agreed schedules and obligations.
We surface hidden constraints, unresolved issues, and technical compromises that are quietly degrading delivery velocity and increasing downstream risk.
Every artifact is explicitly linked to an executive decision, with sufficient depth to support escalation where required, providing clear evidence of delivery confidence and the appropriate path forward.
A clear, consolidated view of delivery confidence, enabling leadership to decide whether to continue as planned or intervene.
A focused view of the most material risks to timeline, cost, and outcome certainty—not a list of issues, but a clear assessment of where delivery commitments are most exposed.
A prioritized plan with clear ownership and immediate next steps, enabling teams to stabilize delivery, restore control, or execute a structured reset.
Confirm scope, objectives, concerns, and timelines.
Review plans, RAID logs, and governance artifacts.
Short discussions with sponsor, PM/PMO lead, and key technical leads.
Present scorecard, findings, and the 30-day action plan.
A focused, low-footprint validation designed to move from initial alignment to decision-ready deliverables within 10 business days requiring less than four hours of total team involvement.
Aligning the review to key decision priorities and areas of concern.
We work with the executive sponsor to define the critical questions that must be answered to support confident decision-making.
Independent assessment of the core delivery evidence behind reported status.
We review delivery artifacts, dependency chains, financial commitments, and governance materials to establish a clear view of delivery health.
Validating key delivery assumptions against actual execution conditions.
We engage only the most critical delivery leads for brief, targeted sessions to validate evidence and confirm plan feasibility.
Delivery of a clear, decision-ready view of delivery health and next steps.
We present the Delivery Health Scorecard, Critical Risk & Exposure Map, and 30-Day Corrective Roadmap—enabling leadership to continue, intervene, or reset with confidence.
Examples of how the diagnostic has shifted critical delivery decisions, protected investment from avoidable risk, and stabilized delivery outcomes
Challenged ‘green’ reporting and re-sequenced dependencies.
Identified top risks and created a 30-day stabilization plan before go-live.
Improved governance cadence and reduced delivery variance.
If you need an independent view of delivery health for a current initiative, begin with a short intake. We review the information provided and propose a scoped Health Check with defined timing and indicative effort.
